Navigation Links
Covance to Present at UBS Global Life Sciences Conference
Date:9/18/2009

PRINCETON, N.J., Sept. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 21, 2009 at 10:00 a.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
2. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
3. Covance to Present at the Drug Information Associations 45th Annual Meeting
4. Covance Elects John McCartney to Companys Board of Directors
5. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
6. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
7. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
8. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
9. Covance Purchases Equity Stake in Caprion Proteomics
10. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
11. Covance Decides to Pursue Its Original Preclinical Strategy in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... PA (PRWEB) , ... August 16, 2017 , ... ... taking part in sessions at the ISPE Annual Meeting and Expo , to ... San Diego Marina. The event’s theme is “Driving innovation to advance patient therapies.” , ...
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar Biologics ... secured $2M in funding from an impressive group of investors, including Rev1 Ventures, ... Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering that ...
(Date:8/16/2017)... Mass. , Aug. 16, 2017  This year,s edition of the ... leader in life sciences workforce solutions, has made the list for the ... 5000 recognizes the nation,s fastest-growing private companies based on a set of ... 50, which includes the fastest-growing companies in the Bay State ... Inc. 5000 ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):